Found: 17
Select item for more details and to access through your institution.
Canine oral primary melanoma cells exhibit shift to mesenchymal phenotype and phagocytic behaviour.
- Published in:
- Veterinary & Comparative Oncology, 2019, v. 17, n. 3, p. 211, doi. 10.1111/vco.12464
- By:
- Publication type:
- Article
A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice.
- Published in:
- Archives of Virology, 2015, v. 160, n. 10, p. 2525, doi. 10.1007/s00705-015-2525-9
- By:
- Publication type:
- Article
Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients.
- Published in:
- PLoS ONE, 2021, v. 16, n. 11, p. 1, doi. 10.1371/journal.pone.0260155
- By:
- Publication type:
- Article
The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis.
- Published in:
- Oncogene, 2003, v. 22, n. 43, p. 6725, doi. 10.1038/sj.onc.1206781
- By:
- Publication type:
- Article
Mcl-1 Antisense Therapy Chemosensitizes Human Melanoma in a SCID Mouse Xenotransplantation Model.
- Published in:
- Journal of Investigative Dermatology, 2003, v. 120, n. 6, p. 1081, doi. 10.1046/j.1523-1747.2003.12252.x
- By:
- Publication type:
- Article
Molecular aspects of pregnancy. Cyclic AMP- and differentiation-dependent regulation of the proximal gene promoter in term villous trophoblasts.
- Published in:
- Molecular Human Reproduction, 1999, v. 5, n. 6, p. 573, doi. 10.1093/molehr/5.6.573
- By:
- Publication type:
- Article
Tumor-targeted gene delivery of tumor necrosis factor-α induces tumor necrosis and tumor regression without systemic toxicity.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 8, p. 673, doi. 10.1038/sj.cgt.7700487
- By:
- Publication type:
- Article
Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036506
- By:
- Publication type:
- Article
Single HA2 Mutation Increases the Infectivity and Immunogenicity of a Live Attenuated H5N1 Intranasal Influenza Vaccine Candidate Lacking NS1.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018577
- By:
- Publication type:
- Article
Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005984
- By:
- Publication type:
- Article
Elevated Serum Concentrations of the Angiogenesis Inhibitor Endostatin in Preeclamptic Women.
- Published in:
- Reproductive Sciences, 2003, v. 10, n. 7, p. 412, doi. 10.1016/S1071-5576(03)00142-4
- By:
- Publication type:
- Article
Elevated Serum Concentrations of the Angiogenesis Inhibitor Endostatin in Preeclamptic Women.
- Published in:
- Reproductive Sciences, 2003, v. 10, n. 7, p. 412, doi. 10.1016/S1071-55760300142-4
- By:
- Publication type:
- Article
In situdetection of protein–DNA interactions in filamentous fungi by in vivo footprinting.
- Published in:
- Nucleic Acids Research, 1998, v. 26, n. 16, p. 3862, doi. 10.1093/nar/26.16.3862
- By:
- Publication type:
- Article
A Novel Type of Influenza Vaccine: Safety and Immunogenicity of Replication-Deficient Influenza Virus Created by Deletion of the Interferon Antagonist NS1.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 3, p. 354, doi. 10.1086/649428
- By:
- Publication type:
- Article
Nitrate and the GATA factor AreA are necessary for in vivo binding of NirA, the pathway-specific transcriptional activator of Aspergillus nidulans.
- Published in:
- Molecular Microbiology, 2002, v. 44, n. 2, p. 573, doi. 10.1046/j.1365-2958.2002.02911.x
- By:
- Publication type:
- Article
Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0143269
- By:
- Publication type:
- Article
Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0138722
- By:
- Publication type:
- Article